Marshall Wace North America’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $398K | Buy |
+2,314
| New | +$398K | ﹤0.01% | 1120 |
|
|
2021
Q2 | – | Sell |
-90,295
| Closed | -$12.2M | – | 1937 |
|
|
2021
Q1 | $12.2M | Buy |
+90,295
| New | +$12.2M | 0.05% | 353 |
|
|
2020
Q3 | – | Sell |
-108,294
| Closed | -$10.3M | – | 1578 |
|
|
2020
Q2 | $10.3M | Buy |
108,294
+103,349
| +2,090% | +$9.85M | 0.07% | 264 |
|
|
2020
Q1 | $444K | Buy |
+4,945
| New | +$444K | ﹤0.01% | 779 |
|
|
2019
Q4 | – | Sell |
-256,338
| Closed | -$10.1M | – | 1718 |
|
|
2019
Q3 | $10.1M | Buy |
256,338
+119,406
| +87% | +$4.72M | 0.06% | 259 |
|
|
2019
Q2 | $5.63M | Sell |
136,932
-246,234
| -64% | -$10.1M | 0.03% | 336 |
|
|
2019
Q1 | $17.8M | Buy |
383,166
+377,548
| +6,720% | +$17.6M | 0.13% | 154 |
|
|
2018
Q4 | $245K | Buy |
+5,618
| New | +$245K | ﹤0.01% | 921 |
|
|
2018
Q3 | – | Sell |
-117,693
| Closed | -$5.71M | – | 1528 |
|
|
2018
Q2 | $5.71M | Buy |
+117,693
| New | +$5.71M | 0.03% | 478 |
|
|
2017
Q4 | – | Sell |
-159,799
| Closed | -$5.91M | – | 1699 |
|
|
2017
Q3 | $5.91M | Buy |
159,799
+136,966
| +600% | +$5.07M | 0.04% | 502 |
|
|
2017
Q2 | $685K | Sell |
22,833
-44,730
| -66% | -$1.34M | 0.01% | 1030 |
|
|
2017
Q1 | $1.76M | Buy |
+67,563
| New | +$1.76M | 0.01% | 603 |
|